Transurethral Resection Of The Prostate Role In Patients With Elevated PSA Level, Minor Lower Urinary Tract Symptoms, And Bladder Outlet Obstruction
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology
Article Date: 24 Jul 2008 - 0:00 PDT
| Patient / Public: | ![]() |
2.67 (3 votes) |
| Healthcare Prof: | ![]() |
3.5 (4 votes) |
UroToday.com - In the online edition of European Urology, Dr. Koenraad van Renterghem and associates presented their data on how to manage patients with an elevated PSA and proven bladder outlet obstruction. Between 2005 and 2007, 33 consecutive men with an elevated PSA, a negative prostate biopsy, minor LUTS (IPSS 0-19), and with urodynamics evidence of bladder outlet obstruction all underwent a transurethral resection of the prostate (TURP).
The mean patient age was 66.6 years and the mean PSA level before TURP was 8.2ng/ml. They divided the patients into:
Group 1: Only histologic BPH on TURP
Group 2: Aggressive CaP
Group 3: Non-aggressive CaP and/or BPH.
Pre-TURP levels before surgery were similar. The mean IPSS before TURP was 6.8. On urodynamics, the mean PdetQmax in all patients was 80.3cm H2O.
After the TURP, 27 men (81.8%) were found to only have histologic BPH. Two men (6.1%) had Gleason scores 8 and 6 (large volume) CaP and were labeled as aggressive CaP (T1b). Both underwent radical prostatectomy three months later. The four other patients (12.1%) had a small amount of CaP (stage T1a).
The mean PSA value after TURP was 0.6ng/ml and was the same in groups 1 and 3. Six months after TURP, mean IPSS in groups 1 and 3 were 2.5 and 2.4, respectively. Quality of life in group 1 improved from 1.8 before the TURP to 0.7 and in group 3 it improved from 1.7 to 0.6. Seven of the men from group 3 had a postoperative urodynamics evaluation and the mean PdetQmax post-TURP was 16.4cm H2O.
The study suggests that this approach for patients with mild LUTS and an elevated PSA has good outcomes. However, medical management for the LUTS, with continued biopsies as indicated, would be another approach to this problem.
van Renterghem K, Van Koeveringe G, Achten R, van Kerrebroeck P
Eur Urol. 2008 Jun 26. Epub ahead of print.
doi:10.1016/j.eururo.2008.06.069
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/115983.php>
APA
http://www.medicalnewstoday.com/releases/115983.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




